Saudi Pharmaceutical Industries and Medical Appliances Corporation (2070.SR)

Growth (Per Share)

Revenue 5Y
Revenue 3Y
Earnings 5Y
Earnings 3Y
Dividend 5Y
Dividend 3Y

Capital Efficiency

ROIC
ROE
ROA
ROTA

Capital Structure

Market Cap3.10B
EV3.10B
Cash
Current Ratio
Debt/Equity
Net Debt/EBITDA
Show More

Select a metric from the list below to chart it

Income Statement
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Revenue
346.0
392.3
455.0
491.3
369.9
340.2
414.3
416.1
389.5
380.6
Revenue % Chg.
4.2%
13.4%
16.0%
8.0%
-24.7%
-8.0%
21.8%
0.4%
-6.4%
-2.3%
Cost of Revenue
158.8
180.3
232.9
248.6
181.9
174.6
267.3
231.5
224.1
229.5
Gross Profit
187.2
212.0
222.0
242.7
188.0
165.6
147.0
184.6
165.4
151.1
Gross Profit Margin
54.1%
54.0%
48.8%
49.4%
50.8%
48.7%
35.5%
44.4%
42.5%
39.7%
R&D Expenses
8.6
5.4
2.2
11.4
Selling, General, & Admin Expenses
74.6
147.5
152.1
53.6
30.6
36.5
42.4
Other Expenses
56.8
73.9
110.7
108.9
115.9
127.1
Operating Income
55.2
64.6
69.9
42.8
51.6
165.6
-25.9
40.9
11.7
-29.8
Operating Income Margin
16.0%
16.5%
15.4%
8.7%
14.0%
48.7%
-6.2%
9.8%
3.0%
-7.8%
Total Other Income/Expenses Net
21.2
26.0
30.4
66.7
15.1
-162.2
-94.1
1.3
-2.7
-8.9
Income Before Tax
76.4
90.6
100.4
109.5
66.8
3.4
-119.9
42.2
9.0
-38.8
Income Before Tax Margin
22.1%
23.1%
22.1%
22.3%
18.1%
1.0%
-28.9%
10.1%
2.3%
-10.2%
Income Tax Expense
8.5
11.7
3.3
6.7
Net Income
71.2
84.6
95.3
100.5
52.7
27.4
-128.4
33.3
7.1
-45.4
Net Income Margin
20.6%
21.6%
20.9%
20.5%
14.2%
8.1%
-31.0%
8.0%
1.8%
-11.9%
Weighted Avg. Shares Out
120.0
107.8
120.0
120.0
120.0
120.0
120.0
120.0
120.0
EPS
0.6
0.8
0.8
0.8
0.4
0.2
-1.1
0.3
0.1
EPS % Chg.
14.5%
32.3%
1.4%
5.4%
-47.8%
-47.6%
-78.8%
Weighted Avg. Shares Out Dil
120.0
107.8
120.0
120.0
120.0
120.0
120.0
120.0
120.0
EPS Diluted
0.6
0.8
0.8
0.8
0.4
0.2
-1.1
0.3
0.1
Interest Expense
0.5
0.7
0.8
7.2
3.9
7.6
11.0
8.9
8.4
9.4
EBIT
75.9
89.9
99.6
102.3
62.8
-4.2
-130.9
33.2
0.6
-48.2
EBIT Margin
21.9%
22.9%
21.9%
20.8%
17.0%
-1.2%
-31.6%
8.0%
0.2%
-12.7%
Depreciation & Amortization
8.3
-30.4
33.0
23.5
26.2
EBITDA
84.1
89.9
99.6
102.3
62.8
-4.2
-161.3
66.2
24.1
-22.0
EBITDA Margin
24.3%
22.9%
21.9%
20.8%
17.0%
-1.2%
-38.9%
15.9%
6.2%
-5.8%